EMR vs AME
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 12, 2026
EMR
AME
Investment Advisor Scores
AME
AI Analyst Insights
Detailed Metrics Comparison
| Metric | EMR | AME | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 23.3645 | 26.9542 | EMR |
| PEG Ratio | 2.0511 | 2.6801 | EMR |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 7.1% | 17.3% | AME |
| Earnings Growth | 18.5% | 15.6% | EMR |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 53.3/100 | 55.7/100 | AME |
| Profit Margin | 14.2% | 19.9% | AME |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | STRONG BUY | AME |
Relative Price Performance (Last 90 Days)
Current Technical Phase
EMR
MarkupPrice above SMA50, rising 50-day trend (1.6% over 20 days), RSI 55
AME
DistributionPrice near a flattening SMA50 (slope -0.8%) with fading momentum, RSI 48
Fundamentals Snapshot
| Metric | EMR | AME |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 23.1 | 24.9 |
| Trailing P/E | 35.0 | 33.6 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.2% |
| Gross Margin | 0.5% | 0.4% |
| Operating Margin | 0.3% | 0.3% |
| EPS | 4.79 | 7.09 |
| Dividend Yield | 0.00% | 0.01% |